Operator
Good afternoon. Thank you for joining us today to discuss OptimizeRx Corporation's first quarter ended March 31, 2021. Speaking on the call today is OptimizeRx's chief executive officer, William Febbo; and the company's chief financial officer, Doug Baker. Miriam Paramore, the company's chief strategy officer; and chief commercial officer, Stephen Silvestro will be present for the Q&A.
Following the remarks, they will open the call for questions. Before we conclude today's call, I'll provide some important cautions regarding the forward-looking statements made by management during today's call. I'd like to remind everyone that today's call is being recorded and will be made available for replay via webcast only, and instructions and today's press release are in the investor section of the company's website. Now, I turn the call over to OptimizeRx CEO, Will Febbo.